denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.Hematology Disease Topics & Pathways:
Clinical Trials, Biological therapies, Epidemiology, Non-Biological therapies, Age Inequities, Workforce, Health Outcomes Research, Elderly, Health Disparities Research, Diversity, Equity, Inclusion, and Accessibility (DEI/DEIA) , Patient-Reported Outcomes, Real World Evidence, Therapies, Registries, Adverse Events, Study Population, Diversity, Equity, and Inclusion (DEI), Clinical Practice (e.g. Guidelines, Health Outcomes and Services, and Survivorship, Value; etc.)
Abstracts incorporating the principles of geriatrics into research and clinical practice of caring for older adults with hematologic conditions (both malignant and nonmalignant) are of increasing interest to ASH participants. The ASH Poster Walk on Geriatric Hematology will aggregate these diverse abstracts into a single discussion, allowing key opinion leaders to provide context on the current state of the art in geriatric hematology, covering topics including elderly-specific therapeutic trials, frailty and geriatric assessment.
The following abstracts will be featured in this session:
Emicizumab Prophylaxis in Persons with Hemophilia A, Aged ≥50 Years, with Comorbidities – Pooled Data from Four Phase III Studies (HAVEN 1, 3, and 4, and STASEY), Victor Jimenez-Yuste
Development and Testing of a Lymphoma Clinical Trials Specific Frailty Index: A Secondary Analysis of the LY.12 Clinical Trial, Abi Vijenthira
A Cross-Sectional Analysis of County-Level Social Vulnerability and Physical Frailty Among Adults with Hematological Malignancies, Shakira Grant